Manuel, Oriol <br/><br/>
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.  [electronic resource] 

 -  Clinical transplantation   
 - 794-800 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-0012 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-0012.2009.01205.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Cytomegalovirus--drug effects<br/>Cytomegalovirus Infections--prevention & control<br/>Female<br/>Ganciclovir--administration & dosage<br/>Glomerular Filtration Rate<br/>Humans<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Survival Rate<br/>Tissue Distribution<br/>Valganciclovir